Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Fernando Rivero-Crespo"'
Autor:
Ignacio J. Amat-Santos, Giorgio Marengo, Juan Pablo Sánchez-Luna, Carlos Cortés Villar, Fernando Rivero Crespo, Víctor Alfonso Jiménez Díaz, José María de la Torre Hernández, Armando Pérez de Prado, Manel Sabaté, Ramón López-Palop, José Miguel Vegas Valle, Javier Suárez de Lezo, Clara Fernandez Cordon, Jose Carlos Gonzalez, Mario García-Gómez, Alfredo Redondo, Manuel Carrasco Moraleja, J. Alberto San Román
Publikováno v:
Journal of Cardiovascular Development and Disease, Vol 11, Iss 1, p 14 (2023)
Background: Quantitative flow ratio (QFR) virtual angioplasty with pre-PCI residual QFR showed better results compared with an angiographic approach to assess post-PCI functional results. However, correlation with pre-PCI residual QFR and post-PCI fr
Externí odkaz:
https://doaj.org/article/7ae1088d9f04494bbc42f5536a614a36
Autor:
Rafael Vázquez-García, Dolores Cañadas-Pruaño, Josep Gómez-Lara, Etelvino Silva, Alejandro Gutierrez-Barrios, Fernando Alfonso, Fernando Rivero Crespo, Livia L. Gheorghe, Elena Izaga-Torralba, Ricardo Zayas Rueda, Germán Calle-Pérez, Inmaculada Noval-Morillas
Publikováno v:
The American Journal of Cardiology. 141:31-37
Coronary flow reserve (CFR) is a well-validated flow-based physiological parameter that has shown value in clinical risk stratification. CFR can be invasively assessed, classically by Doppler and, more recently, by thermodilution with saline boluses
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f19f952df6b2353e7635701c6971c0d
https://doi.org/10.1016/j.amjcard.2020.11.011
https://doi.org/10.1016/j.amjcard.2020.11.011
Autor:
Elena Izaga Torralba, Alejandro Gutiérrez Barrios, Fernando Rivero Crespo, Josep Gómez Lara, Fernando Alfonso
Publikováno v:
JACC: Cardiovascular Interventions. 16:S34
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9d2ac4d3a9c2abc7a345c2435dabf0ef
https://doi.org/10.1016/j.jcin.2023.01.123
https://doi.org/10.1016/j.jcin.2023.01.123
Autor:
Teresa Alvarado Casas, Antonio Manuel Rojas González, Fernando Rivero Crespo, Paula Antuña Álvarez, Guillermo Diego Nieto, Fernando Alfonso
Publikováno v:
Medicina Intensiva. 45:187-189
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1039193bb914d94d82a7bfa0ad014fba
https://doi.org/10.1016/j.medin.2019.04.005
https://doi.org/10.1016/j.medin.2019.04.005
Autor:
Fernando Rivero Crespo, Fernando Alfonso, Paula Antuña Álvarez, Antonio Manuel Rojas González, Guillermo Diego Nieto, Teresa Alvarado Casas
Publikováno v:
Medicina Intensiva (English Edition). 45:187-189
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ff5460b3879a23d9e8c68030d46906ce
https://doi.org/10.1016/j.medine.2021.01.003
https://doi.org/10.1016/j.medine.2021.01.003
Autor:
Juan Manuel Nogales-Asensio, Joan Antoni Gómez-Hospital, Juan Francisco Oteo-Domínguez, Victor M Aragón-Extremera, Jesús M. Jiménez-Mazuecos, Fernando Carrasco, Francisco Bosa-Ojeda, José R. López-Mínguez, Fernando Rivero-Crespo, Sebastián Romaní
Publikováno v:
Catheterization and Cardiovascular Interventions. 92:261-268
Objectives To compare the safety and efficacy of the new cobalt-chromium bioactive stent Titan Optimax® (Hexacath, France) with its predecessor, Titan-2®. Background The TIOMAX registry includes 784 patients who underwent percutaneous coronary inte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::42424739929e1601f2497225d1710e5a
https://doi.org/10.1002/ccd.27326
https://doi.org/10.1002/ccd.27326
Autor:
Adam de Belder, Wail Nammas, Antti Ylitalo, Juhani Airaksinen, Fernando Rivero-Crespo, Pasi P. Karjalainen, Kari Kervinen
Publikováno v:
Journal of Interventional Cardiology. 30:114-123
Objectives We performed a post hoc analysis of outcome in patients with, versus those without, calcified target lesions from the BASE ACS trial. Background The outcome of contemporary stent implantation in patients with calcified lesions presenting w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cccdf4abdc392c1ffc189a0342069eae
https://doi.org/10.1111/joic.12357
https://doi.org/10.1111/joic.12357
Autor:
Pasi P. Karjalainen, Bernard De Bruyne, Matti Niemelä, Wail Nammas, Fernando Rivero-Crespo, Jussi Sia, Mikko Pietilä, Adam de Belder
Publikováno v:
Scandinavian Cardiovascular Journal. 50(4):218-223
The BASE-ACS trial demonstrated non-inferiority of titanium-nitride-oxide-coated bioactive stents (BAS), versus everolimus-eluting stents (EES), for major adverse cardiac events (MACE) at 1- and 2-year follow-up, in patients with acute coronary syndr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6ae1ff93d50aa706d9cfb39afff171e
http://juuli.fi/Record/0286176116
http://juuli.fi/Record/0286176116
Autor:
Angel Sanchez Recalde, Ramón López Palop, Fernando Alfonso, José M. de la Torre Hernández, Federico Gimeno, Xavier Carrillo, José A. Diarte de Miguel, German Zavala, Helena Tizón Marcos, Antonio Ramírez Moreno, Jose D. Cascon, Antonio L. Arrebola Moreno, Leire Andraka, Tamara Garcia Camarero, Juan Francisco Oteo Dominguez, Francisco Bosa, Omar Abdul-Jawad Altisent, Antonio Gomez Menchero, Luz Muñoz, Armando Pérez de Prado, Felipe Hernández, Manuel Jiménez Navarro, Juan Sanchis, Fernando Rivero Crespo
Publikováno v:
Revista Española de Cardiología. 68:838-845
Resumen Introduccion y objetivos El periodo de uso recomendado del tratamiento antiagregante plaquetario combinado doble tras implante de stents farmacoactivos va de los 6 a los 12 meses o mas. Ensayos recientes indican que es seguro utilizar un trat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f5477ac99ae6480bed1b571a132d5275
https://doi.org/10.1016/j.recesp.2015.01.010
https://doi.org/10.1016/j.recesp.2015.01.010
Autor:
Omar Abdul-Jawad Altisent, Tamara Garcia Camarero, Helena Tizón Marcos, Juan Francisco Oteo Dominguez, Francisco Bosa, Leire Andraka, Ramón López Palop, José M. de la Torre Hernández, Federico Gimeno, Antonio Gomez Menchero, Armando Pérez de Prado, Fernando Alfonso, Xavier Carrillo, German Zavala, Jose D. Cascon, Felipe Hernández, Manuel Jiménez Navarro, Juan Sanchis, Fernando Rivero Crespo, Antonio L. Arrebola Moreno, José A. Diarte de Miguel, Luz Muñoz, Antonio Ramírez Moreno, Angel Sanchez Recalde
Publikováno v:
Revista Española de Cardiología (English Edition). 68:838-845
Introduction and objectives The recommendation for dual antiplatelet therapy following drug-eluting stent implantation ranges from 6 months to 12 months or beyond. Recent trials have suggested the safety of a 6-month dual antiplatelet therapy regimen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1544f01097b23e90a768d26570a897d0
https://doi.org/10.1016/j.rec.2015.01.008
https://doi.org/10.1016/j.rec.2015.01.008